CDXS — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

12.22

Margin Of Safety %

Put/Call OI Ratio

0.09

EPS Next Q Diff

-0.21

EPS Last/This Y

0.13

EPS This/Next Y

-0.01

Price

1.98

Target Price

6.1

Analyst Recom

1.67

Performance Q

21.47

Upside

-1,019.2%

Beta

2.11

Ticker: CDXS

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	CDXS	1.255	0.05	0.00	2413
2026-03-10	CDXS	1.235	0.05	561.40	2422
2026-03-11	CDXS	1.275	0.55	500.00	3581
2026-03-12	CDXS	1.705	0.92	0.28	4446
2026-03-13	CDXS	1.71	0.92	0.28	4446
2026-03-17	CDXS	1.465	0.72	0.06	5299
2026-03-18	CDXS	1.46	0.72	0.00	5296
2026-03-19	CDXS	1.665	0.72	0.00	5310
2026-03-20	CDXS	1.595	0.71	0.00	5322
2026-03-23	CDXS	1.605	0.10	0.00	1401
2026-03-24	CDXS	1.68	0.10	0.00	1405
2026-03-25	CDXS	1.755	0.09	0.00	1615
2026-03-26	CDXS	1.67	0.09	0.00	1620
2026-03-27	CDXS	1.585	0.08	0.00	1646
2026-03-30	CDXS	1.53	0.08	0.00	1646
2026-03-31	CDXS	1.635	0.08	1.83	1647
2026-04-01	CDXS	1.735	0.09	0.00	1663
2026-04-02	CDXS	1.815	0.09	999.99	1697
2026-04-06	CDXS	1.88	0.09	0.03	1698
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	CDXS	1.25	73.1	-	-0.60
2026-03-10	CDXS	1.23	73.1	-	-0.60
2026-03-11	CDXS	1.28	73.1	-	-0.60
2026-03-12	CDXS	1.70	73.1	-	-0.60
2026-03-13	CDXS	1.61	73.1	-	-0.60
2026-03-17	CDXS	1.47	-	-	-0.63
2026-03-18	CDXS	1.45	-	-	-0.63
2026-03-19	CDXS	1.66	-	-	-0.63
2026-03-20	CDXS	1.60	48.0	-	-0.46
2026-03-23	CDXS	1.61	48.0	-	-0.46
2026-03-24	CDXS	1.68	48.0	-	-0.46
2026-03-25	CDXS	1.75	48.0	-	-0.46
2026-03-26	CDXS	1.67	48.0	-	-0.46
2026-03-27	CDXS	1.59	48.0	-	-0.46
2026-03-30	CDXS	1.53	58.0	-	-0.37
2026-03-31	CDXS	1.64	58.0	-	-0.37
2026-04-01	CDXS	1.74	58.0	-	-0.37
2026-04-02	CDXS	1.82	58.0	-	-0.37
2026-04-06	CDXS	1.88	58.0	-	-0.37
2026-04-07	CDXS	1.98	58.0	-	-0.37
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	CDXS	-33.19	5.74	8.29
2026-03-10	CDXS	-33.19	5.74	8.29
2026-03-11	CDXS	-33.19	5.74	10.46
2026-03-12	CDXS	-33.19	5.74	10.46
2026-03-13	CDXS	-33.19	5.74	10.46
2026-03-17	CDXS	-33.06	5.73	10.40
2026-03-18	CDXS	-33.06	5.73	10.40
2026-03-19	CDXS	-33.06	5.73	10.40
2026-03-20	CDXS	-33.06	5.73	10.40
2026-03-23	CDXS	-33.06	6.17	10.40
2026-03-24	CDXS	-33.06	6.17	10.40
2026-03-25	CDXS	-33.06	6.17	12.22
2026-03-26	CDXS	-33.06	6.17	12.22
2026-03-27	CDXS	-33.06	6.17	12.22
2026-03-30	CDXS	-33.06	6.17	12.22
2026-03-31	CDXS	-33.06	6.17	12.22
2026-04-01	CDXS	-33.06	6.17	12.22
2026-04-02	CDXS	-33.06	6.17	12.22
2026-04-06	CDXS	-33.06	6.27	12.22
2026-04-07	CDXS	-33.06	6.27	12.22
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.11

Avg. EPS Est. Current Quarter

-0.1

Avg. EPS Est. Next Quarter

-0.1

Insider Transactions

-33.06

Institutional Transactions

6.27

Beta

2.11

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

95.3

Max Drawdown 5-Year %

-97.7

Target Price

6.1

P/E

Forward P/E

PEG

P/S

2.56

P/B

3.55

P/Free Cash Flow

EPS

-0.52

Average EPS Est. Cur. Y

-0.37

EPS Next Y. (Est.)

-0.38

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-62.47

Relative Volume

0.88

Return on Equity vs Sector %

-114.5

Return on Equity vs Industry %

-97.9

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.12

EBIT Estimation

◆ CDXS Healthcare

$1.98

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

16/20

Pullback

4/25

Volume

4/15

Valuation

12/20

TP/AR

1/10

Options

0/10

RSI

69.5

Range 1M

82.1%

Sup Dist

9.9%

🚀

Momentum Growth

Ride accelerating trends

WEAK

Momentum

16/25

Growth

20/30

Estimates

0/20

Inst/Vol

8/15

Options

0/10

EPS Yr

13.6%

EPS NY

16.7%

52W%

34.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +208.1% upside

Quality

6/30

Valuation

16/30

Growth

16/25

Stability

5/10

LT Trend

2/5

Upside

+208.1%

Quality

Codexis, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 146

Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.

CDXS

Latest News

—

Caricamento notizie per CDXS…

stock quote shares CDXS – Codexis, Inc. Stock Price stock today

news today CDXS – Codexis, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch CDXS – Codexis, Inc. yahoo finance google finance

stock history CDXS – Codexis, Inc. invest stock market

stock prices CDXS premarket after hours

ticker CDXS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: CDXS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y